Cheng Kong

3.3k total citations · 4 hit papers
47 papers, 2.4k citations indexed

About

Cheng Kong is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Cheng Kong has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Oncology and 11 papers in Physiology. Recurrent topics in Cheng Kong's work include Gut microbiota and health (23 papers), Diet and metabolism studies (11 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). Cheng Kong is often cited by papers focused on Gut microbiota and health (23 papers), Diet and metabolism studies (11 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). Cheng Kong collaborates with scholars based in China, United States and Australia. Cheng Kong's co-authors include Renyuan Gao, Linsheng Huang, Xuebing Yan, Huanlong Qin, Huanlong Qin, Yanlei Ma, Xiao Qu, Yongzhi Yang, Huiyuan Zhu and Xuebing Yan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Cheng Kong

47 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet

2018 398 citations Cheng Kong, Renyuan Gao et al. Nutrition profile →
Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations

2022 237 citations Huiyuan Zhu, Dexi Bi et al. Signal Transduction and Targeted Therapy profile →
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer

2022 154 citations Cheng Kong, Lei Liang et al. Gut profile →
Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15

2024 49 citations Huiyuan Zhu, Dexi Bi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng Kong China	24	1.5k	699	496	265	233	47	2.4k
Beng San Yeoh United States	24	1.3k 0.9×	567 0.8×	194 0.4×	358 1.4×	222 1.0×	69	2.5k
Ravi N. Padia United States	11	1.9k 1.2×	496 0.7×	378 0.8×	156 0.6×	280 1.2×	14	2.5k
Lidia Sánchez‐Alcoholado Spain	21	1.3k 0.9×	816 1.2×	195 0.4×	164 0.6×	171 0.7×	28	2.0k
Arnaud Muller Luxembourg	20	2.3k 1.5×	617 0.9×	277 0.6×	307 1.2×	318 1.4×	42	3.3k
Steven Vanhoutvin Netherlands	15	1.9k 1.2×	756 1.1×	278 0.6×	222 0.8×	297 1.3×	23	3.2k
Sathish Sivaprakasam United States	19	2.5k 1.6×	836 1.2×	402 0.8×	303 1.1×	375 1.6×	38	3.6k
Chaithanya Chelakkot South Korea	10	1.5k 1.0×	407 0.6×	193 0.4×	214 0.8×	186 0.8×	15	2.3k
Yeji Kim South Korea	22	1.4k 0.9×	344 0.5×	176 0.4×	287 1.1×	202 0.9×	72	2.5k
Ashish Gurav United States	5	1.6k 1.1×	508 0.7×	256 0.5×	192 0.7×	291 1.2×	8	2.3k
Romana R. Gerner Austria	19	936 0.6×	318 0.5×	385 0.8×	450 1.7×	173 0.7×	26	2.0k

Countries citing papers authored by Cheng Kong

Since Specialization

Citations

This map shows the geographic impact of Cheng Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Kong more than expected).

Fields of papers citing papers by Cheng Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Kong. The network helps show where Cheng Kong may publish in the future.

Co-authorship network of co-authors of Cheng Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Kong. A scholar is included among the top collaborators of Cheng Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Kong. Cheng Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kong, Cheng, Jinming Li, Guang Liu, et al.. (2024). Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. Microbiome. 12(1). 274–274. 5 indexed citations

Kong, Cheng, et al.. (2024). The past, present, and future of tumour deposits in colorectal cancer: Advancing staging for improved prognosis and treatment decision‐making. Journal of Cellular and Molecular Medicine. 28(16). e18562–e18562. 1 indexed citations

Liu, Guang, Lili Su, Cheng Kong, et al.. (2024). Improved diagnostic efficiency of CRC subgroups revealed using machine learning based on intestinal microbes. BMC Gastroenterology. 24(1). 315–315. 1 indexed citations

Zhang, Xiaolan, et al.. (2024). Colonization of stenotrophomonas and its associated microbiome between paired primary colorectal cancers and their lung metastatic tumors (experimental studies). International Journal of Surgery. 111(2). 2291–2295. 2 indexed citations

Kong, Cheng, Lei Liang, Guang Liu, et al.. (2022). Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer. Gut. 72(6). 1129–1142. 154 indexed citations breakdown →

Zhu, Huiyuan, Dexi Bi, Youhua Zhang, et al.. (2022). Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduction and Targeted Therapy. 7(1). 11–11. 237 indexed citations breakdown →

Gao, Renyuan, Chunyan Wu, Yefei Zhu, et al.. (2022). Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites. Gastroenterology. 163(4). 1024–1037.e9. 67 indexed citations

Kong, Cheng, Xuebing Yan, Yefei Zhu, et al.. (2021). Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling. Cancer Research. 81(17). 4485–4498. 133 indexed citations

Gao, Renyuan, Yefei Zhu, Cheng Kong, et al.. (2021). Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer. Frontiers in Cellular and Infection Microbiology. 11. 657867–657867. 42 indexed citations

10.

Zhang, Sheng, Cheng Kong, Yongzhi Yang, et al.. (2020). Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer. Theranostics. 10(25). 11595–11606. 72 indexed citations

11.

Kong, Cheng, et al.. (2020). The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis. Gland Surgery. 9(4). 936–949. 16 indexed citations

12.

He, Wan, Xiangmei Zhang, Wenwen Li, et al.. (2018). Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report. OncoTargets and Therapy. Volume 11. 7423–7427. 28 indexed citations

13.

Shi, Chenzhang, Hao Li, Linsheng Huang, et al.. (2018). High fat diet exacerbates intestinal barrier dysfunction and changes gut microbiota in intestinal-specific ACF7 knockout mice. Biomedicine & Pharmacotherapy. 110. 537–545. 30 indexed citations

14.

Kong, Cheng, et al.. (2018). Analysis of fecal microbiota in patients with functional constipation undergoing treatment with synbiotics. European Journal of Clinical Microbiology & Infectious Diseases. 37(3). 555–563. 33 indexed citations

15.

Kong, Cheng, Renyuan Gao, Xuebing Yan, Linsheng Huang, & Huanlong Qin. (2018). Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition. 60. 175–184. 398 indexed citations breakdown →

16.

Huang, Linsheng, Renyuan Gao, Xuebing Yan, et al.. (2017). Structure analysis of the gut microbiota in chronic functional constipation patients. 6(2). 121–126. 8 indexed citations

17.

Gao, Renyuan, Cheng Kong, Lyen C. Huang, et al.. (2017). Mucosa-associated microbiota signature in colorectal cancer. European Journal of Clinical Microbiology & Infectious Diseases. 36(11). 2073–2083. 101 indexed citations

18.

Kong, Cheng, Renyuan Gao, Linsheng Huang, & Peng Zhang. (2017). Research progression of gut microbiota and its metabolites in colorectal cancer. 6(5). 421–426. 1 indexed citations

19.

Tran, Sieu L., Michelle F. Maritz, Bing Liu, et al.. (2016). MYC -Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin. Cancer Research. 76(12). 3604–3617. 36 indexed citations

20.

Barnas, G. M., et al.. (1995). Effects of PEEP on Acinar Gas Transfer in Healthy and Lung-Injured Dogs. American Journal of Respiratory and Critical Care Medicine. 152(4). 1241–1247. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact